News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Anthera Pharmaceuticals, Inc. Plans $70 Million IPO
September 16, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bizjournals.com -- A Hayward biotech focused on inflammatory diseases like from cardiovascular disease and lupus filed for one of the first U.S. biotech IPO in two years.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Deals
Novartis bets up to $7.8B for an mRNA-encoded T cell engager from China’s Abogen
October 2, 2026
·
2 min read
·
Tristan Manalac
Immunology and inflammation
Sanofi pays Regeneron $1B upfront to continue search for Dupixent successor
October 1, 2026
·
3 min read
·
Tristan Manalac
Manufacturing
BioNTech to close German manufacturing plants after failing to find buyers
September 30, 2026
·
2 min read
·
Nick Paul Taylor
Business
Summit snags $2B investment from AstraZeneca, clearing financial overhang
September 29, 2026
·
3 min read
·
Tristan Manalac
